Incensus Pharma IvS: Financial statements 2018
CVR: 37162949
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Incensus Pharma IvS (CVR 37162949) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,250 and a net result of DKK -1,352 compared with DKK -1,271 the year before. Equity in the 2018 report amounted to DKK -4,119.
- Gross Profit
- DKK -1,250
- Profit/Loss
- DKK -1,352
- Equity
- DKK -4,119
- Total Assets
- DKK 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -1 t. | -1 t. | -4 t. | - |
| 2017 | - | -1 t. | -1 t. | -3 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Incensus Pharma IvS has published its annual report for 2017. Gross profit came to DKK -1,250, and the net result was DKK -1,271.
About Incensus Pharma IvS
Incensus Pharma IvS was a Danish company of the type Iværksætterselskab based in Hinnerup, founded in 2015. The company has been dissolved on 25 May 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2020, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,625 the year before. Equity in the 2020 report amounted to DKK -7,244.